Search

Your search keyword '"macitentan"' showing total 31 results
Start Over Descriptor "macitentan" Publisher newsrx llc
31 results on '"macitentan"'

2. New Anemia Study Findings Recently Were Reported by Researchers at National Heart Institute (Macitentan in the treatment of pulmonary arterial hypertension)

Subjects
Pulmonary hypertension -- Drug therapy, Physical fitness, Bosentan, Endothelin, Nitric oxide, Medical research, Anemia -- Drug therapy, Drug approval, Macitentan, Health
Abstract

2020 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Hematologic Diseases and Conditions - Anemia. According [...]

Published
2020

3. Investigators from Erasmus University Medical Center Zero in on Endothelin Receptor Antagonists (Simultaneous Quantification of Ambrisentan, Macitentan and Sitaxentan In Human Plasma Using Uplc-ms/ms)

Subjects
Pulmonary hypertension, Physical fitness, Medical centers, Endothelin, Ambrisentan, Macitentan, Hypertension, Finance, Preeclampsia, Eclampsia, Obesity, Health care industry, Research funding, Editors, Health
Abstract

2020 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Endothelin Receptor Antagonists. [...]

Published
2020

4. Data on Endothelin Receptor Antagonists Detailed by Researchers at Erasmus University Medical Center (Simultaneous quantification of ambrisentan, macitentan and sitaxentan in human plasma using UPLC-MS/MS)

Subjects
Pulmonary hypertension, Physical fitness, Medical centers, Endothelin, Ambrisentan, Biochemistry, Macitentan, Hypertension, Obesity, Preeclampsia, Eclampsia, Editors, Health
Abstract

2020 FEB 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Endothelin Receptor Antagonists. [...]

Published
2020

5. Researchers at Institute for Cancer Research and Treatment (IRCCS) Release New Data on Ovarian Cancer (b-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer)

Subjects
Tumor proteins -- Drug therapy, Women's health, Endothelin, Cancer research, Macitentan, Ovarian cancer -- Drug therapy, Anopheles, Editors, Health, Women's issues/gender studies
Abstract

2019 AUG 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on Oncology - Ovarian Cancer have been published. According to news [...]

Published
2019

6. Researchers at Second Military Medical University Report Findings in Liver Function (A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension)

Subjects
Pulmonary hypertension -- Health aspects -- Reports -- Analysis -- Safety and security measures, Physical fitness -- Health aspects -- Reports -- Analysis -- Safety and security measures, Antihypertensive agents -- Health aspects -- Reports -- Analysis -- Safety and security measures, Liver diseases -- Health aspects -- Reports -- Analysis -- Safety and security measures, Endothelin -- Health aspects -- Reports -- Analysis -- Safety and security measures, Liver -- Health aspects -- Reports -- Analysis -- Safety and security measures, Hypertension, Online searching, Ambrisentan, Obesity, Macitentan, Bosentan, Editors, Anemia, Health
Abstract

2019 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Liver Diseases and Conditions - Liver Function. [...]

Published
2019

7. Researchers Submit Patent Application, 'Treatment Of Focal Segmental Glomerulosclerosis With Ccr2 Antagonists', for Approval (USPTO 20190134042)

Subjects
Adrenocortical hormones, Physical fitness, Antihypertensive agents, Angiotensin II receptor blockers, Angiotensin converting enzyme inhibitors, Aliskiren, Valsartan, Proteinuria, Trandolapril, Telmisartan, Ambrisentan, Obesity, Macitentan, Fosinopril, Eprosartan, Bosentan, Perindopril, Editors, Health
Abstract

2019 JUN 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2019

8. Investigators from University Medical Center Zero in on Endothelin Receptor Antagonists [The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-mononitrate (Ismn) and Isosorbide Dinitrate (Isdn) Induced Endothelial Dysfunction, ...]

Subjects
Coronary heart disease -- Care and treatment, Endothelin -- Research, Isosorbide dinitrate -- Usage, Obesity, Endothelium, Macitentan, Physical fitness, Health care industry, Heart failure, Oxidative stress, Medical centers, Editors, Vasodilator agents, Health
Abstract

2019 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Drugs and Therapies - Endothelin Receptor Antagonists are presented [...]

Published
2019

12. Patent Application Titled 'Method Of Treating Pulmonary Arterial Hypertension' Published Online (USPTO 20200155557)

Subjects
Pulmonary hypertension -- Methods, Vardenafil -- Intellectual property -- Methods, Antihypertensive agents -- Methods, Platelet aggregation inhibitors -- Methods -- Intellectual property, Antipsychotic agents -- Methods, Sapropterin dihydrochloride -- Methods, Avanafil -- Methods, Vasodilator agents -- Methods, Paliperidone -- Methods, Hypertension, Treprostinil, Riociguat, Sitaxsentan, Selexipag, Ambrisentan, Iloprost, Macitentan, Epoprostenol, Bosentan, Editors, Health
Abstract

2020 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2020

13. New Peptide Receptors Study Findings Recently Were Reported by Researchers at Aarhus University (Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy)

Subjects
Pulmonary hypertension -- Research -- Reports, Antihypertensive agents -- Research -- Reports, Endothelin -- Research -- Reports, Cancer research -- Reports, Biochemistry -- Reports, Membrane proteins -- Reports, Ambrisentan, Hypertension, Macitentan, Proteins, Peptides, Bosentan, Editors, Business, Health, Health care industry, Aarhus University -- Reports
Abstract

2020 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Membrane Proteins - Peptide Receptors is the subject of a report. According [...]

Published
2020

14. 'Combination Therapy For Pulmonary Hypertension' in Patent Application Approval Process (USPTO 20200069658)

Subjects
VIVUS Inc. -- Intellectual property, Pulmonary hypertension, Tezosentan, Antihypertensive agents, Avanafil, Pharmaceutical industry -- Intellectual property, Ambrisentan, Hypertension, Macitentan, Riociguat, Biotechnology, Bosentan, Editors, Diseases, Biotechnology industry, Pharmaceuticals and cosmetics industries, World Health Organization
Abstract

2020 MAR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors GU, Leo (Saratoga, CA); NAKAGAKI, Paul C. (Mountain View, [...]

Published
2020

15. Patent Issued for Method Of Treating Pulmonary Arterial Hypertension (USPTO 10,576,083)

Subjects
Pulmonary hypertension -- Methods, Antihypertensive agents -- Methods, Platelet aggregation inhibitors -- Intellectual property -- Methods, Antipsychotic agents -- Methods, Sapropterin dihydrochloride -- Methods, Povidone -- Intellectual property -- Methods, Vasodilator agents -- Methods, Paliperidone -- Methods, Ambrisentan, Hypertension, Iloprost, Macitentan, Treprostinil, Epoprostenol, Bosentan, Editors, Health
Abstract

2020 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Cipla (UK) Limited (Weybridge, Surrey, United Kingdom) has been issued patent number 10,576,083, according to [...]

Published
2020

16. Patent Issued for Compositions And Methods For Preventing Or Treating Pulmonary Hypertension (USPTO 10,517,917)

Subjects
Pulmonary hypertension -- Prevention -- Methods, Antihypertensive agents -- Methods, Vasodilator agents -- Methods, Ambrisentan, Iloprost, Macitentan, Epoprostenol, Bosentan, Editors, Business, Health
Abstract

2020 JAN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2020

17. Reports Summarize Hypertension Study Results from S. Cadenas-Menendez and Co-Researchers (Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results ...)

Subjects
Pulmonary hypertension -- Care and treatment, Endothelin, Macitentan, Editors, Health, World Health Organization
Abstract

2020 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Cardiovascular Diseases and Conditions - Hypertension. According to [...]

Published
2020

18. 'Methods Of Manufacturing Treprostinil And Treprostinil Derivative Prodrugs' in Patent Application Approval Process (USPTO 20190337888)

Subjects
Insmed Inc. -- Production processes -- Intellectual property, Treprostinil -- Methods, Antihypertensive agents -- Methods, Amino acids -- Methods, Iloprost -- Methods, Pharmaceutical industry -- Production processes -- Intellectual property -- Methods, Macitentan, Riociguat, Fainting, Bosentan, Editors, Health
Abstract

2019 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- A patent application by the inventors Malinin, Vladimir (Bridgewater, NJ); Perkins, Walter (Bridgewater, NJ); Leifer, [...]

Published
2019

19. New Hypertension Study Findings Reported from Monash University (Selective ETA versus dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats)

Subjects
Hypertension, Endothelin, Sunitinib, Macitentan, Cancer treatment, Angiogenesis inhibitors, Cardiovascular diseases, Toxicity, Antineoplastic agents, Tumors, Health
Abstract

2019 OCT 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Cardiovascular Diseases and Conditions - Hypertension. According to [...]

Published
2019

20. Findings in Hypertension Reported from Duke University Hospital (A Retrospective Analysis of Adherence to Risk Evaluation and Mitigation Strategies Requirements for Pulmonary Arterial Hypertension Drugs)

Subjects
Pulmonary hypertension -- Research -- Drug therapy, Antihypertensive agents -- Research, Drugs -- Research, Medical research, Risk assessment, Ambrisentan, Hypertension, Macitentan, Cardiovascular diseases, Bosentan, Editors, Health
Abstract

2019 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Researchers detail new data in Cardiovascular Diseases and Conditions - Hypertension. According to news [...]

Published
2019

21. New Data from West Virginia University Illuminate Findings in Heart Failure (Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic ...)

Subjects
United Therapeutics Corp., Heart failure -- Research -- Drug therapy, Pulmonary hypertension -- Research -- Drug therapy, Antihypertensive agents -- Research, Drugs -- Usage -- Research, Biotechnology industries, Hypertension, Macitentan, Heart diseases, Cardiovascular diseases, Bosentan, Editors, Heart valve diseases, Health, West Virginia University
Abstract

2019 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Data detailed on Heart Disorders and Diseases - Heart Failure have been presented. According to [...]

Published
2019

22. Findings from Regina Elena Institute of Cancer Research Provides New Data about Ovarian Cancer (b-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer)

Subjects
Tumor proteins, Endothelin, Cancer research, Macitentan, Ovarian cancer, Anopheles, Editors, Health
Abstract

2019 AUG 12 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- Investigators discuss new findings in Oncology - Ovarian Cancer. According to news reporting [...]

Published
2019

23. Patent Issued for Methods Of Manufacturing Treprostinil And Treprostinil Derivative Prodrugs (USPTO 10,343,979)

Subjects
Insmed Inc. -- Intellectual property, Pulmonary hypertension -- Methods, Treprostinil -- Methods, Antihypertensive agents -- Methods, Heart diseases -- Methods, Amino acids -- Methods, Iloprost -- Methods, Pharmaceutical industry -- Intellectual property -- Methods, Hypertension, Macitentan, Cardiovascular diseases, Fainting, Bosentan, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries, Health, New York Heart Association
Abstract

2019 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Malinin, Vladimir [...]

Published
2019

24. Research Conducted by L. Chellini and Co-Researchers Has Updated Our Knowledge about Ovarian Cancer (Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer)

Subjects
Elsevier Science B.V., Periodical publishing, Endothelin, Cancer research, Integrins, Cancer metastasis, Macitentan, Ovarian cancer, Muscle proteins, Proteins, Actin, Editors, Health
Abstract

2019 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at OBGYN & Reproduction Week -- Investigators publish new report on Oncology - Ovarian Cancer. According to news reporting [...]

Published
2019

25. University of New Mexico Reports Findings in Chronic Kidney Disease (A Dual Blocker of Endothelin A/b Receptors Mitigates Hypertension but Not Renal Dysfunction In a Rat Model of Chronic Kidney Disease and Sleep Apnea)

Subjects
Hypertension, Endothelin, Medical research, Sleep apnea, Macitentan, Chronic kidney failure, Kidney diseases, Rodents, Apnea, Kidney failure, Editors, Health
Abstract

2019 JUN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Kidney Diseases and Conditions - Chronic Kidney Disease are presented [...]

Published
2019

26. Research from University of Melbourne Yields New Findings on Endothelins (Role of endothelin-1 clearance in the haemodynamic responses to endothelin-1 in the pulmonary and hindquarter vasculature of anaesthetised rats)

Subjects
Antihypertensive agents -- Research, Endothelin -- Research, Ambrisentan, Macitentan, Proteins, Peptides, Bosentan, Editors, Biological sciences, Health
Abstract

2019 MAY 21 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Data detailed on Intercellular Signaling Peptides and Proteins - Endothelins have been presented. According [...]

Published
2019

27. Patent Application Titled 'Method Of Treating Hypertension' Published Online (USPTO 20190125756)

Subjects
Cipla Ltd. -- Intellectual property, Pharmaceutical industry -- Intellectual property -- Methods, Vardenafil -- Methods, Avanafil -- Methods, Sapropterin dihydrochloride -- Methods, Pulmonary hypertension -- Methods, Vasodilator agents -- Methods, Platelet aggregation inhibitors -- Methods, Antihypertensive agents -- Methods, Sitaxsentan, Macitentan, Hypertension, Bosentan, Iloprost, Editors, Treprostinil, Anopheles, Ambrisentan, Epoprostenol, Health
Abstract

2019 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2019

28. Studies from Chiesi Farmaceutici S.p.A. in the Area of Pulmonary Hypertension Described [Pharmacological Characterization of a Highly Selective Rho Kinase (Rock) Inhibitor and Its Therapeutic Effects In Experimental Pulmonary Hypertension]

Subjects
Macitentan, Medical research, Respiratory tract diseases, Pulmonary hypertension, Protein kinases, Lung diseases, Hypertension, Editors, Health
Abstract

2019 MAY 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Lung Diseases and Conditions - Pulmonary Hypertension. According [...]

Published
2019

29. Reports Outline Hypertension Findings from T. Tynan and Colleagues (Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan)

Subjects
Endothelin -- Analysis, Industrial research -- Australia -- Analysis, Medical research -- Analysis, Pulmonary hypertension -- Analysis, Antihypertensive agents -- Analysis, Cardiovascular diseases, Macitentan, Hypertension, Public health, Bosentan, Ambrisentan, Editors, Research and development, Health
Abstract

2019 APR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Investigators discuss new findings in Cardiovascular Diseases and Conditions - Hypertension. According to news [...]

Published
2019

30. Patent Application Titled 'Method Of Treating Hypertension' Published Online (USPTO 20190076441)

Subjects
Cipla Ltd. -- Intellectual property, Pharmaceutical industry -- Intellectual property -- Methods, Vardenafil -- Methods, Avanafil -- Methods, Sapropterin dihydrochloride -- Methods, Pulmonary hypertension -- Methods, Vasodilator agents -- Methods, Platelet aggregation inhibitors -- Methods, Antihypertensive agents -- Methods, Sitaxsentan, Macitentan, Hypertension, Bosentan, Iloprost, Editors, Treprostinil, Anopheles, Ambrisentan, Epoprostenol, Health
Abstract

2019 APR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2019

31. Actelion Receives Complete Response Letter from U.S. FDA for OPSUMIT[R] Macitentan Supplemental New Drug Application

Subjects
United States. Food and Drug Administration, Johnson & Johnson, Pharmaceutical industry, Macitentan, Pulmonary hypertension, Editors, Health, Opsumit (Medication)
Abstract

2019 JAN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results